Company intelligence / Profile preview

Vascular Graft Solutions

Tel Aviv, Tel Aviv District, Israelgraftsolutions.com ↗

Ownership: Private
Development stage: Other

Overview

Vascular Graft Solutions has developed and commercialized the VEST external scaffold for saphenous vein grafts, which has demonstrated significant reduction in vein graft disease and improved clinical outcomes in randomized controlled trials. The VIOLA system enables clampless proximal anastomosis during CABG. Their technologies are supported by robust clinical evidence and are increasingly adopted as standard of care in cardiac surgery[1][2][3].

Therapeutic areas: Cardiovascular
Modalities: DeviceMedical device (external scaffold, anastomosis tool)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Vascular Graft Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular Graft Solutions.

Explore the full profile